BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32780783)

  • 1. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
    Mukherjee M; Goswami S
    PLoS One; 2020; 15(8):e0237559. PubMed ID: 32780783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
    Islam MR; Hoque MN; Rahman MS; Alam ASMRU; Akther M; Puspo JA; Akter S; Sultana M; Crandall KA; Hossain MA
    Sci Rep; 2020 Aug; 10(1):14004. PubMed ID: 32814791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.
    Hosseini Rad Sm A; McLellan AD
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
    Srivastava R; Daulatabad SV; Srivastava M; Janga SC
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of transition to transversion ratio in the stem region of RNA secondary structure of untranslated region of SARS-CoV-2.
    Dash M; Meher P; Aditya Kumar ; Satapathy SS; Namsa ND
    PeerJ; 2024; 12():e16962. PubMed ID: 38666080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33239366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p.
    Imperatore JA; Cunningham CL; Pellegrene KA; Brinson RG; Marino JP; Evanseck JD; Mihailescu MR
    Nucleic Acids Res; 2022 Jan; 50(2):1017-1032. PubMed ID: 34908151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.
    Álvarez-Díaz DA; Franco-Muñoz C; Laiton-Donato K; Usme-Ciro JA; Franco-Sierra ND; Flórez-Sánchez AC; Gómez-Rangel S; Rodríguez-Calderon LD; Barbosa-Ramirez J; Ospitia-Baez E; Walteros DM; Ospina-Martinez ML; Mercado-Reyes M
    Infect Genet Evol; 2020 Oct; 84():104390. PubMed ID: 32505692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time audio and visual display of the Coronavirus genome.
    Temple MD
    BMC Bioinformatics; 2020 Oct; 21(1):431. PubMed ID: 33008363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
    Pachetti M; Marini B; Benedetti F; Giudici F; Mauro E; Storici P; Masciovecchio C; Angeletti S; Ciccozzi M; Gallo RC; Zella D; Ippodrino R
    J Transl Med; 2020 Apr; 18(1):179. PubMed ID: 32321524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense.
    Xia X
    Mol Biol Evol; 2020 Sep; 37(9):2699-2705. PubMed ID: 32289821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
    Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach for COVID-19 treatment by micro-RNA.
    El-Nabi SH; Elhiti M; El-Sheekh M
    Med Hypotheses; 2020 Oct; 143():110203. PubMed ID: 33017912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic.
    Martin J; Klapsa D; Wilton T; Zambon M; Bentley E; Bujaki E; Fritzsche M; Mate R; Majumdar M
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The establishment of reference sequence for SARS-CoV-2 and variation analysis.
    Wang C; Liu Z; Chen Z; Huang X; Xu M; He T; Zhang Z
    J Med Virol; 2020 Jun; 92(6):667-674. PubMed ID: 32167180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant analysis of 1,040 SARS-CoV-2 genomes.
    Rouchka EC; Chariker JH; Chung D
    PLoS One; 2020; 15(11):e0241535. PubMed ID: 33152019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
    Dinka H; Milkesa A
    Infect Genet Evol; 2020 Oct; 84():104386. PubMed ID: 32473977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.
    Biswas NK; Majumder PP
    Indian J Med Res; 2020 May; 151(5):450-458. PubMed ID: 32474553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis.
    Singh KK; Chaubey G; Chen JY; Suravajhala P
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C258-C267. PubMed ID: 32510973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.